MOBILE, Ala.–(BUSINESS WIRE)–TruBridge, Inc. (NASDAQ: TBRG), a leading provider of revenue cycle management and healthcare technology solutions for rural and community healthcare organizations, today announced that it will release its financial results for the third quarter ended September 30, 2025, on Thursday, November 6, 2025, after the market closes. The Company will host a conference … [Read more…]
Ninja Swirl™ is featured in the Season 9 reunion episode as SharkNinja showcases its fast, culture-driven marketing approach NEEDHAM, Mass.–(BUSINESS WIRE)–SharkNinja, Inc. (NYSE: SN), a global product design and technology company, today announced a partnership with Netflix’s Love Is Blind. The partnership is a fun play on one of the season’s most viral moments featuring … [Read more…]
CAL101 is a first-in-class monoclonal antibody targeting S100A4, a DAMP protein implicated in severe, life-threatening fibrotic diseases CAL101 being investigated in Phase 2 IPF Study; enrollment ongoing at sites in the USA, UK, EU, Turkey and South Korea OSLO, Norway & BOSTON–(BUSINESS WIRE)–Calluna Pharma AS, a clinical stage biotechnology company pioneering first-in-class antibodies to treat … [Read more…]
HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, inflammatory and autoimmune diseases, today announced the pricing of an underwritten public offering of 13,700,000 shares of its common stock at a price to the public of $18.25 per share. Gross … [Read more…]
TOKYO & BASKING RIDGE, N.J.–(BUSINESS WIRE)–The first patient has been dosed in the DESTINY-Lung06 phase 3 trial evaluating ENHERTU® (trastuzumab deruxtecan) plus pembrolizumab versus pembrolizumab, platinum-based chemotherapy and pemetrexed as a first-line treatment in patients with unresectable, locally advanced or metastatic HER2 overexpressing and PD-L1 TPS <50% non-squamous non-small cell lung cancer (NSCLC). ENHERTU is … [Read more…]
New EZ2 DNA Investigator Sep&Prep Kit automates sexual assault sample processing, improving sperm DNA recovery and separation from victim DNA Workflow on EZ2 Connect Fx delivers high-quality DNA in under 2.5 hours, minimizing hands-on time and variability with current manual process QIAGEN to showcase new kit and forensics portfolio at upcoming ISHI 2025 meeting GERMANTOWN, … [Read more…]
KALISPELL, Mont.–(BUSINESS WIRE)–Paynela, LLC the healthcare fintech company redefining how patients pay for and access prescription medications, announced today that it has officially expanded its operations to Kalispell, Montana. The move underscores Paynela’s continued growth and its mission to make healthcare payments more transparent, efficient, and patient-centered. The company’s new location in Kalispell positions it … [Read more…]
ATLANTA–(BUSINESS WIRE)–A new era in Health Savings Account (HSA) growth and optimization begins with the official launch of MaxHSA, a digital-first platform created to help consumers maximize their HSA contributions without reducing take-home pay. Founded by respected industry veterans Sanders McConnell and Bill Stuart and launching under parent company Benegames, Inc., MaxHSA is the first … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Aseptic Processing of Pharmaceutical and Biotech Products Course (Dec 11th – Dec 12th, 2025)” training has been added to ResearchAndMarkets.com’s offering. This comprehensive course covers fundamental principles, advanced techniques, and regulatory insights necessary for success in aseptic processing. Explore the critical practices and regulatory requirements essential for maintaining sterility and ensuring product quality … [Read more…]
Insulet launches campaign inspired by the International Diabetes Federation’s focus on diabetes, well-being, and the workplace “The Day Diabetes Showed Up to Work” campaign recognizes the unique needs of a person with diabetes in their professional life with a new global survey and resources Data shows that over 1 in 3 respondents feel the overall … [Read more…]
